Author

Matti Korhonen

Finnish Red Cross

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Assay:CRISPR screen· 1 Approach:deep learning· 1

Frequent Co-Authors

Diana SchenkweiniD· 3 shared Emmi JärveläiD· 3 shared Helka GöösiD· 3 shared Seppo Ylä-HerttualaiD· 3 shared Erja KerkeläiD· 2 shared Farhana JahaniD· 2 shared Henrik PaavilaineniD· 2 shared Jan KoskiiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Diana SchenkweinORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Efficient NK cell transduction with VSV-G-pseudotyped lentiviral vectors

Emmi Järvelä, Jan Koski, Farhana Jahan, Antti Tuhkala, Mira Saari, Manar Elmadani, Kari Salokas, Laurens Veltman, Lotta Andersson, Erja Kerkelä, Hekim Can, Marie C. Nyman, Seppo Ylä-Herttuala, Markku T Varjosalo, Diana Schenkwein, , Helka Göös

This study optimizes VSV-G-pseudotyped lentiviral transduction of NK cells by improving activation, construct design, and enhancer use, achieving high efficiency without compromising cell function.

Molecular Therapy Advances · May 5, 2026Peer-reviewedImmunology

Feeder cell - the key component in producing scalable and fit NK cells for therapeutic use

Mira Saari, Farhana Jahan, Lotta Andersson, Anna Syreeni, Pirjo Vehmaan-Kreula, Jan Koski, Emmi Järvelä, Erja Kerkelä, Henrik Paavilainen, Diana Schenkwein, Seppo Ylä-Herttuala, Kim K. Vettenranta, Helka Göös, Matti Korhonen

This study evaluates engineered K562 feeder cells for enhancing NK cell expansion and function in ex vivo cultures, showing up to 500-fold higher yields compared to feeder-free systems.

bioRxiv · Apr 23, 2026 · PreprintImmunology

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface

Jonas Bouhlal, Emmi Jokinen, Petra Johanna Nygren, Diogo Dias, Aleksandr Ianevski, Jay Klievink, Hanna Lähteenmäki, Salomé Decombis, Hanna Duàn, Emmi Järvelä, Emma Saarinen, Anna Näätänen, Konstantin Matjusinski, Tiina Kasanen, Tiina Hannunen, , Satu M. Mustjoki

The paper identifies drugs that rewiring the cancer-immune interface by enhancing NK cell function and tumor susceptibility through multimodal screening approaches.

bioRxiv · Apr 17, 2026 · PreprintCancer Biology